The FDA approval of lenacapavir as a form of preexposure prophylaxis (PrEP) is a major step for HIV prevention, but its ...

WHO releases new guidelines recommending injectable lenacapavir for HIV prevention: Geneva Wednesday, July 16, 2025, 10:00 Hrs [IST] The World Health Organization (WHO) released n ...

Kenya is set to roll out the long-acting injectable HIV Pre-Exposure prophylaxis (PrEP) Lenacapavir by January 2026 following its approval by the World Health Organization.

The global recommendation – issued Monday at the International AIDS Conference in Kigali, Rwanda – comes about a month after ...

A breakthrough HIV drug that only needs to be injected twice a year to offer near-total protection from the virus and ...

A landmark breakthrough in HIV prevention — a scientific feat decades in the making — received final approval from the Food ...

The money is not nearly enough to put two to four million people per year in South Africa on the lenacapavir jab, and even if it were, the country’s health system won’t be able to roll out the ...

Despite the recent approval of lenacapavir as a twice yearly PrEP, there is still a need for choice in HIV prevention, argue ...

The country isn’t getting extra money from the Global Fund to Fight Aids, TB and Malaria; it has to use cash from a grant it ...

South Asia has achieved its highest-ever immunization coverage for children, with notable progress in India and Nepal, ...

Whitman-Walker Health highlights the importance of PrEP in HIV prevention and encourages collective action to increase access ...

An investigational once-weekly oral antiretroviral therapy (ART) combination effectively maintained viral suppression in ...